期刊文献+

血液透析患者高同型半胱氨酸血症、微炎症状态与外周动脉疾病的关系 被引量:3

Relationship between hyperhomocysteinemia,micro inflammatory status and peripheral arterial disease in hemodialysis patients
下载PDF
导出
摘要 目的探讨血液透析患者同型半胱氨酸(Hcy)、超敏C反应蛋白(hsCRP)与外周动脉疾病(peripheralarterial disease,PAD)的相关性。方法将踝臂指数(ankle-brachial index,ABI)作为诊断PAD的指标,47例维持性血液透析(MHD)患者,按所测ABI值分为正常组(ABI≥0.9)26例和PAD组(ABI<0.9)21例,测定两组的血清尿素氮(BUN)、血清肌酐(SCr)、血清白蛋白(Alb)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、Hcy、hsCRP等指标。结果两组患者透析时间、收缩压(SBP)、舒张压(DBP)、BUN、SCr、TG、TC、LDL-C、HDL-C比较差异无统计学意义。PAD组年龄为(56.0±5.9)岁,正常组年龄为(50.0±8.4)岁,差异有统计学意义(P<0.05);PAD组hsCRP为(6.26±2.32)mg/L,正常组hsCRP为(3.46±1.26)mg/L,差异有统计学意义(P<0.01);PAD组Hcy为(20.85±7.70)μmol/L,正常组Hcy(13.02±4.88)μmol/L,PAD组Hcy显著高于正常组(P<0.01);PAD组Alb为(32.67±3.90)g/L,正常组Alb为(37.54±4.89)g/L,PAD组Alb显著低于正常组(P<0.01);相关性分析提示ABI与年龄、hsCRP、Hcy明显负相关,与AlB呈正相关(r值分别为-0.326、-0.615、-0.509、0.425,均P<0.01)。Logistic回归分析显示hsCRP(OR=2.94,95%CI=1.437~6.112,P<0.01)、Hcy(OR=1.199,95%CI=1.013~1.419,P<0.05)是影响ABI的独立相关因素。结论微炎症状态、高同型半胱氨酸血症参与了血液透析患者的动脉硬化和PAD的进程。 Objective To evaluate the correlation among homocysteine(Hcy),hypersensitivity C-reactive protein(hsCRP) and peripheral arterial disease(PAD) in hemodialysis patients. Methods The ankle-brachial index(ABI) was used to be a diagnostic indicator of PAD.According to ABI,47 hemodialysis patients were randomly divided into two groups,including normal group(n=26,ABI≥0.9) and PAD group(n=21,ABI0.9).Then,the level of BUN,SCr,Alb,TG,TC,LDL-C,HDL-C,Hcy and hsCRP were measured in both groups. Results There were no significant statistic difference between two groups in dialysis time,SBP,DBP,BUN,SCr,TG,TC,LDL-C and HDL-C.In PAD group,age was(56.0±5.9) years and in normal group,age(50.0±8.4) years,there was statistically significant difference(P0.05);PAD group showed hsCRP(6.26±2.32) mg/L and normal group hsCRP(3.46±1.26) mg/L,the difference was statistically significant(P0.01);PAD group showed Hcy(20.85±7.70) μmol/L and normal group Hcy(13.02±4.88) μmol/L,the difference was statistically significant(P0.01);PAD group had Alb(32.67±3.90) g/L and normal group Alb(37.54±4.89) g/L,the difference was statistically significant(P0.01).Correlation analysis suggests that ABI and the factors including age,hsCRP levels,Hcy were negatively related while positively related with Alb(respecttively r=-0.326,-0.615,-0.509,0.425,P0.01).Logistic regression analysis showed that hsCRP(OR=2.94,95%CI=1.437-6.112,P0.01),Hcy(OR=1.199,95%CI=1.013-1.419,P 0.05) was related factors of the independent effect on ABI. Conclusion The inflammation and state of homocysteine appear to be involved in the process of arteriosclerosis and PAD in blood dialysis patients.
出处 《临床荟萃》 CAS 2011年第20期1755-1758,共4页 Clinical Focus
关键词 肾疾病 肾透析 高同种半胱氨酸血症 炎症 kidney disease renal dialysis hyperhomocysteinemia inflammation
  • 相关文献

参考文献23

  • 1Tremblay R, Bonnardeaux A, Geadah D, et al. Hyperhomocysteinemia in hemodialysis patients: effects of 12- month supplementation with hydrosoluble vitamins[J]. Kidney Int,2000,58(2) :851-858.
  • 2Berqstrom J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?[J]. Semin Dial, 2000, 13 ( 3 ) : 163- 175.
  • 3Ohkuma T, Minagawa T, Takada N, et al. C-reactive protein, lipoprotein (a), homocysteine, and male sex contribute to carotid atheroselerosis in peritoneal dialysis patients[J]. Am J Kidney Dis, 2003,42(2) : 355-361.
  • 4Stenvinkel P, Heimburger O,Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure[J]. Kidney Int,1999,55(5):1899-1911.
  • 5Foley RN. Should hemoglobin be normalized in uremic patients?[J]. Clin Nephrol, 2002,58 (Suppl 1) :S58-61.
  • 6Leskinen Y, Salenius JP, Lehtimaki T. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure:requirements for diagnostics[J]. Am J Kidney Dis,2002,40(3):472-479.
  • 7Ono K, Tsuchida A, Kawai H, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients[J]. J Am Soc Nephrol, 2003, 14 (6): 1591-1598.
  • 8Hooi JD, Kesterb AD, Stoffersa HE, et al, Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study[J].J Clin Epidemiol, 2004,57 ( 3 ) :294-300.
  • 9OurielK,McDonnell AE,Metz CE,et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease[J]. Surgery,1982,91(6):686-693.
  • 10Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease[J].Circulation, 1998, 97 (2): 138- 141.

二级参考文献8

  • 1Yu HH,Joubran R,Asmi M,et al.Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls.Clin Chem,2000,46(3):258-264
  • 2Jacobsen DW.Cardiovascular disorders (risk assessment).Clin Chem,1993,65:367r-373r
  • 3Perna AF,Ingrosso D,Satta E,et al.Metabolic consequences of hyperhomocysteinemia in uremia.Am J Kidney Dis,2001,38(4 Suppl 1):s85-90
  • 4Tremblay R,Bonnardeaux A,Geadah D,et al.Hyperhomocysteinemia in hemodialysis patients:effects of 12-month supplementation with hydrosoluble vitamins.Kidney Int,2000,58(2):851-858
  • 5Sutton-Tyrrell K,Wolf SK,Kuller LH.Blood pressure slows the progression of carotid stenosis in patients with isolated systolic hypertension.Stroke,1994,25(2):44
  • 6Tawakol A,Omland T,Gerhard M,et al.Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans.Circulation,1997,95(4):1119-1121
  • 7Dalton ML,Gadson PF,Wrenn RW,et al.Homocysteine signal cascade:production of phospholipids,activation of protein kinase C,and the induction of C-fos and x-myb in smooth muscle cells.FASEB J,1997,11(8):703-711
  • 8许竹梅.超声检测动脉粥样硬化的进展:颈动脉内膜中层厚度的意义[J].心血管病学进展,1998,19(6):354-357. 被引量:49

共引文献11

同被引文献31

  • 1陈香美,张冬.应重视维持性血液透析患者微炎症状态的认识[J].中国血液净化,2005,4(2):59-61. 被引量:102
  • 2冯利平,张玲,钟玲,朱冬菊,刘玲.维生素E对维持性血液透析患者氧化应激及微炎症状态的影响[J].中国实用内科杂志,2007,27(3):215-217. 被引量:16
  • 3刘德慧,李宓.维持性血液透析患者动脉粥样硬化的发病机制研究进展[J].中国血液净化,2007,6(10):562-565. 被引量:5
  • 4Hatamizadeh P, Ravel V, Lukowsky LR, et al. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease[J]. Nephrol Dial Transplant, 2013, 28(11) : 2889-2898.
  • 5Collins AJ, Kasiske B, Herzoq C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States [J]. Am J Kideny Dis,2005,45(1) :5-7.
  • 6Gordon L, McGrowder DA, Pena YT, et al. Effect of yoga exercise therapy on oxidative stress indicators with end-stage renal disease on hemodialysis[J]. Int J Yoga, 2013, 6(1) : 31-38.
  • 7Gade K, Blaschke S, Rodenbeck A, et al. Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysisz potential role of homocysteine and parathyroid hormone [J]. Kidney Blood Press Res, 2013, 37(4/5) : 458-463.
  • 8Francisco RC, Aloha M, Ram6n PS. Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorusand cardiac structure and function in patients with end-stage renal disease[J]. Int Urol Nephrol, 2013,45(5) : 1373-1378.
  • 9Kaysen GA, Dubin JA, Mailer HG, et al The acute- phaseresponse varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study GroupFJ3. Kidney Int, 2000,58(1) :346-352.
  • 10Noordzi JM, Korevaar JC, Bos WJ, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients [J]. Nephrol Dial Transplant, 2006, 21(9): 2513-2520.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部